This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Gastrointestinal Adverse Effects With Divalproex Sodium and Valproic Acid

Peter G. Wagner, Steven R. Welton, and Constance M. Hammond

Published: September 30, 2000

Article Abstract

Letter to the Editor

Sir: The retrospective analysis by Zarate et al. comparingtolerability and efficacy of valproic acid and divalproex sodiumin an inpatient psychiatric setting found a statistically significantdifference in the incidence of gastrointestinal adverse effects.The authors also noted that the dosing frequency wassignificantly higher with valproic acid. It is important to notethat the patients in both groups were naive to treatment withvalproic acid and that the duration of data collection was lessthan 5 weeks.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 61

Quick Links: Neurologic and Neurocognitive , Seizure

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...

Read More...